Ejandra, Fabian L.
HRN: 28-82-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/18/2025
10/07/2025
IV
600mg
Q8H
Nonhealing Wound, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes